Fengling Li

发表

High PARP-1 expression predicts poor survival in acute myeloid leukemia and PARP-1 inhibitor and SAHA-bendamustine hybrid inhibitor combination treatment synergistically enhances anti-tumor effects

Jian Huang, Jie Jin, Yungui Wang, 2018, EBioMedicine.

MAP4K1 functions as a tumor promotor and drug mediator for AML via modulation of DNA damage/repair system and MAPK pathway.

Jian Huang, Jie Jin, Yungui Wang, 2021, EBioMedicine.

MAP4K1 functions as a tumor promotor and drug mediator for AML via modulation of DNA damage/repair system and MAPK pathway

Jian Huang, Jie Jin, Yungui Wang, 2021, EBioMedicine.

A novel alkylating deacetylase inhibitor molecule EDO-S101 in combination with cytarabine synergistically enhances apoptosis of acute myeloid leukemia cells

Jie Jin, Shihui Mao, Xia Li, 2019, Medical Oncology.

The global burden and attributable risk factors of chronic lymphocytic leukemia in 204 countries and territories from 1990 to 2019: analysis based on the global burden of disease study 2019

Fengling Li, Hua-feng Wang, Xiangjie Lin, 2021, Biomedical engineering online.

Clinical characteristics and prognostic values of 1p32.3 deletion detected through fluorescence in situ hybridization in patients with newly diagnosed multiple myeloma: a single-center study in China

Min Yang, Jie Jin, P. Lin, 2019, Frontiers of Medicine.

Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia

Y. Zhai, Jian Huang, Jiajia Pan, 2022, Journal of translational medicine.

Apigenin and Abivertinib, a novel BTK inhibitor synergize to inhibit diffuse large B-cell lymphoma in vivo and vitro

Jie Jin, Xia Li, Xin Huang, 2020, Journal of Cancer.

Posaconazole oral suspension for secondary antifungal prophylaxis in allogeneic stem cell transplantation recipients: a retrospective study

Youqian Hu, Fengling Li, P. Ye, 2022, BMC Infectious Diseases.

CPT1B, a metabolic molecule, is also an independent risk factor in CN-AML.

Jian Huang, Jie Jin, Jiajia Pan, 2020, Cancer biomarkers : section A of Disease markers.

High expression of INHBA is an adverse prognostic factor for de novo acute myeloid leukemia

Fengling Li, R. Pei, Ying Lu, 2018, Leukemia & lymphoma.

Abivertinib synergistically strengthens the anti‐leukemia activity of venetoclax in acute myeloid leukemia in a BTK‐dependent manner

Jie Jin, Jiajia Pan, Shihui Mao, 2020, Molecular oncology.

Characterization of the Newly Established Homoharringtonine- (HHT-) Resistant Cell Lines and Mechanisms of Resistance

Chao Hu, Xia Li, Xin Huang, 2022, Journal of oncology.

RARγ-rearrangements resemble acute promyelocytic leukemia and benefit from 3 + 7 regimen

Jie Jin, Jinghan Wang, Fengling Li, 2019, Leukemia & lymphoma.

Global, regional, and national burdens of leukemia from 1990 to 2017: a systematic analysis of the global burden of disease 2017 study

Jian Huang, Jie Jin, Jiajia Pan, 2021, Aging.

FLOT1 knockdown inhibits growth of AML cells through triggering apoptosis and pyroptosis

Jian Huang, Jiajia Pan, Chao Hu, 2023, Annals of Hematology.

High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts

Jian Huang, Jie Jin, Yungui Wang, 2018, EBioMedicine.

Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development

Jian Huang, Fengling Li, Hua-feng Wang, 2021, Experimental Hematology & Oncology.

Spermatogenesis associated serine rich 2 like plays a prognostic factor and therapeutic target in acute myeloid leukemia by regulating the JAK2/STAT3/STAT5 axis

Jian Huang, Chao Hu, Shihui Mao, 2023, Journal of Translational Medicine.

Development and validation of a novel circular RNA as an independent prognostic factor in acute myeloid leukemia

Jian Huang, Jie Jin, Yungui Wang, 2021, BMC Medicine.

Dihydropyrimidinase‐like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia

Min Yang, Jiajia Pan, Chao Hu, 2023, Cancer medicine.

Ibrutinib Suppresses Early Megakaryopoiesis but Enhances Proplatelet Formation

Min Yang, Jian Huang, Jie Jin, 2020, Thrombosis and Haemostasis.

Abivertinib inhibits megakaryocyte differentiation and platelet biogenesis

Min Yang, Jian Huang, Yungui Wang, 2021, Frontiers of Medicine.

Abivertinib, a novel BTK inhibitor: anti-leukemia effects and synergistic efficacy with Homoharringtonine in acute myeloid leukemia.

Jian Huang, Yungui Wang, Jiajia Pan, 2019, Cancer letters.

Expression and clinical significance of phospholipase D1 in de novo acute myeloid leukemia

Jie Jin, Fengling Li, R. Pei, 2020, Hematology.

Promising efficacy of novel BTK inhibitor AC0010 in mantle cell lymphoma

Jian Huang, Jiajia Pan, Jinghan Wang, 2018, Journal of Cancer Research and Clinical Oncology.

Homoharringtonine Synergizes Strongly with Venetoclax Against the Early T-Cell Progenitor Acute Lymphoblastic Leukemia：from Bench to Bed

L. Ghoda, G. Marcucci, Min Yang, 2022, Blood.

Loss of IRF8 inhibits the growth of acute myeloid leukemia cells

Fengling Li, P. Ye, R. Pei, 2023, Annals of Hematology.

ACSL5, a prognostic factor in acute myeloid leukemia, modulates the activity of Wnt/β-catenin signaling by palmitoylation modification

Jian Huang, Yungui Wang, Jiajia Pan, 2023, Frontiers of Medicine.

High Expression of CD300A Predicts Poor Survival in Acute Myeloid Leukemia

Meng-xia Yu, Fengling Li, P. Ye, 2023, Acta Haematologica.

Higher efficacy of Etoposide + Cytarabine Plus Pegfilgrastim in poorly mobilizing Multiple Myeloma and lymphoma Patients.

Fengling Li, P. Ye, R. Pei, 2023, Cytotherapy.

Inhibition of CPT1a as a prognostic marker can synergistically enhance the antileukemic activity of ABT199

Jian Huang, Jie Jin, Yungui Wang, 2021, Journal of translational medicine.

ACC010, a novel BRD4 inhibitor, synergized with homoharringtonine in acute myeloid leukemia with FLT3 ‐ITD

Jian Huang, Jiajia Pan, H. Tong, 2022, Molecular Oncology.

The ferroptosis landscape in acute myeloid leukemia

Chao Hu, Jinghan Wang, Xia Li, 2023, Aging.

Homoharringtonine synergizes with venetoclax in early T cell progenitor acute lymphoblastic leukemia: Bench and bed.

Fengling Li, L. Nguyen, Dinh Hoa Hoang, 2024, Med.

High expression of BCAT1 sensitizes AML cells to PARP inhibitor by suppressing DNA damage response.

Jiajia Pan, Jinghan Wang, Shihui Mao, 2024, Journal of molecular medicine.